Vitamin D and Multiple Sclerosis Study
There were 468 patients monitored closely over the course of 5 years. Researchers looked at the Vitamin D levels of patients with a first event suggestive of MS. Trying to predict the diseases activity and prognosis in these patients and the link between Multiple Sclerosis progression and Vitamin D levels.
After only one year, by increasing the patients Vitamin D levels by 50 nmol/L they had a 57% reduced risk of developing new brain lesions. 57% of patients had a lower risk of relapse. Patients showed a 25% lower yearly increase in T2 lesion size. And perhaps most promising, patients showed a .41 percent lower yearly loss in brain size.
In this study the Vitamin D levels were a direct indicator of the progression of the disease. Monitored at the first sign of MS symptoms and followed for the next 5 years.
Patients with lower Vitamin D levels were more likely to develop new brain lesions and had a worse overall prognosis.
The study’s findings, combined with the previously found evidence that Vitamin D deficiency was a contributing risk factor for MS, suggests that Vitamin D supplementation is extremely important for MS treatment and prevention.
Vitamin D and MS Study
Lead research, Dr.Alberto Ascherio, a professor at the Harvard School of Public Health is convinced that Vitamin D can be very beneficial to Multiple Sclerosis Patients.
“These findings, combined with previous evidence that Vitamin D deficiency is a risk factor for MS, and the immunological effects of Vitamin D strongly suggest that maintaining an adequate Vitamin D status is important in the treatment of MS,” Says Dr.Alberto Ascherio.